BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Designing Cosmetic Materials for the Skin
DTSTART:20181022T131500
DTEND:20181022T141500
DTSTAMP:20260528T175149Z
UID:a9aae9f6b065c04fa9b3a59ada4013b9e415ead125c0209cfbe4ba0e
CATEGORIES:Conferences - Seminars
DESCRIPTION:Dr Peter Lersch\, Evonik Germany\nFunction\, aesthetics\, and 
 safety of cosmetic raw materials are key in today’s marketplace\, where 
 the consumer is looking for a desired effect such as a reduction in lines 
 and wrinkles\, the removal of age spots\, or long wear in a lipstick. The 
 majority of Skin Care products and a very significant percentage of toilet
 ry products are emulsions. The basic components of these formulations are 
 emulsifiers\, emollients and consistency enhancers. Additional value can b
 e given to these formulations by including active ingredients with specifi
 c dermatological effects. The selection of these components determines the
  success of a formulation. The chosen emulsifier is not only crucial for t
 he stability of an emulsion\, because the cosmetic formulation is finally 
 considered to be a fine-tuned delivery system to achieve a desired effect.
  Some of the challenges faced in the development of new cosmetic formulati
 ons will be presented as well as how scientific progress related to the un
 derstanding of structure and properties\, surface & polymer chemistry\, an
 d nanotechnology are all coming together to drive the development of new c
 osmetic raw materials.\n\nExp Dermatol. 2014 Nov\;23(11):853-5. doi: 10.11
 11/exd.12526.\nTopical ceramides neither enhance UVB-induced apoptosis in 
 normal human keratinocytes nor affect viability in UVB-irradiated reconstr
 ucted human epidermis.\nGrether-Beck S1\, Felsner I\, Koehler T\, Farwick 
 M\, Lersch P\, Rawlings AV\, Krutmann J.\n\nJ Drugs Dermatol. 2011 Sep\;10
 (9):990-1000.\nEfficacy of cream-based novel formulations of hyaluronic ac
 id of different molecular weights in anti-wrinkle treatment.\nPavicic T1\,
  Gauglitz GG\, Lersch P\, Schwach-Abdellaoui K\, Malle B\, Korting HC\, Fa
 rwick M.\n\nBio: Peter Lersch heads Innovation Management in Evonik’s Bu
 siness Line Personal Care. He has worked in Evonik and its predecessor com
 panies in different R&D management and technical positions for 29 years.\n
 Born in 1962\, Peter holds a doctorate in Technical Chemistry/Chemical Eng
 ineering from the University of Essen\, Germany. In 1989\, he joined then 
 Th. Goldschmidt AG in Essen as a Laboratory Manager in the silicone chemis
 try unit. In 1996\, Peter accepted an expatriate assignment as Technology 
 Transfer Manager in the United States. After his return to Germany by mid 
 1999\, he was tasked to set up and head a new department focusing on Cosme
 tic active Ingredients and became actively involved in the successful acqu
 isition of Dutch biotechnology company Cosmoferm from DSM. While retaining
  R&D responsibilities for actives\, by early 2006 Peter was appointed as H
 ead of Product Development for Care Ingredients & Biotechnology for Deguss
 a and later Evonik’s Care & Surface Specialties Business Unit\, and was 
 in charge of R&D for the complete portfolio of cosmetic raw materials as w
 ell as managing “Open Innovation” projects. In 2012\, he took over his
  current position and since then leads Evonik’s global Personal Care App
 lication Research and Technical Service Teams with a focus on customer-dri
 ven innovation and interdisciplinary collaborations. Since 2016\, Peter is
  also responsible for “Cosmetic Solutions”\, one of the six Evonik gro
 wth fields.  \nPeter’s research activity is documented by over 30 Germa
 n patents and numerous foreign patents and as author/co-author of more tha
 n 20 scientific articles.
LOCATION:MXF 1 https://plan.epfl.ch/?room==MXF%201
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR